Supreme Court Agrees To Hear Rezulin Case

Law360, New York (September 25, 2007, 12:00 AM EDT) -- The U.S. Supreme Court has agreed to hear an appeal brought by Pfizer Inc. that raises questions over whether federal regulations exempt drug companies from state product liability claims.

On Tuesday, the High Court granted cert to Pfizer's appeal in a product liability case brought by people who claim they were harmed by taking the diabetes drug Rezulin before it was pulled from the market in March 2000.

Pfizer filed its petition to the Supreme Court in May, six months after the case was reinstated by...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.